Eunsung

Eunsung Global is a South Korean medical aesthetics and healthcare device company focused on the development, manufacture, and commercialization of energy-based devices. Its portfolio spans HIFU, radiofrequency, laser, needle RF, plasma, cryotherapy, aqua therapy, drug-delivery, and home-care systems for skin treatment, body contouring, and related aesthetic procedures. The company markets products globally and describes itself as a leader in medical aesthetic healthcare devices, with operations centered in Korea and distribution across numerous international markets. Recent public information highlights regulatory progress for its RF product Duet V, including U.S. FDA clearance/certification references and Brazilian ANVISA certification in 2025. Eunsung Global appears to be a commercially active device manufacturer rather than a therapeutics developer, with no evidence of a drug-development clinical pipeline.